Real Time Touch

new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)

Real Time Touch

Universite De Strasbourg patents

Recent patent applications related to Universite De Strasbourg. Universite De Strasbourg is listed as an Agent/Assignee. Note: Universite De Strasbourg may have other listings under different names/spellings. We're not affiliated with Universite De Strasbourg, we're just tracking patents.

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "U" | Universite De Strasbourg-related inventors

Anti-claudin 1 monoclonal antibodies for the prevention and treatment of hepatocellular carcinoma

Use of anti-claudin 1 monoclonal antibodies and pharmaceutical compositions thereof, for the prevention and/or treatment of hepatocellular carcinoma in patients suffering from liver disease, in particular liver disease that is not associated with hcv infection or in patients who have been cured from hcv infection. Methods of preventing and/or treating hepatocellular carcinoma by administration of such a monoclonal antibody, or a pharmaceutical composition thereof, are also described. ... Universite De Strasbourg

Metabolically stable apelin analogs in the treatment of disease mediated by the apelin receptor

The invention is related to metabolically stable apelin analogs and their use for the prevention or the treatment of diseases mediated by the apelin receptor in particular of cardiovascular disease (heart failure, hypertension, pulmonary hypertension, kidney failure) and inappropriate vasopressin secretions (siadh).. . ... Universite De Strasbourg

Diagnostic markers for crohn's disease

The invention relates to markers for crohn's disease and to specific compounds for detecting said markers. The invention also relates to methods for detecting, diagnosing and monitoring the progression of crohn's disease as well as to methods for evaluating the efficacy of a treatment for said disease, and to compositions and kits that can be used for implementing said methods.. ... Universite De Strasbourg

Compositions and methods for the treatment of retinal degeneration

The present invention relates to a pharmaceutical composition comprising an inhibitor of eif2α, a compound increasing the expression and/or activity of protein bip and/or an inhibitor of caspase-12, preferably an inhibitor of eif2α and a compound increasing the expression and/or activity of protein bip. The present invention also relates to pharmaceutical compositions and methods for treating retinal degeneration related to ciliary dysfunction.. ... Universite De Strasbourg

Disintegratable core/shell silica particles for encapsulating and releasing bioactive macromolecules

The present invention relates to disintegratable core/shell silica particles encapsulating a bioactive macromolecule or bioactive macromolecule cluster in an active conformation, a method for producing the same, and uses thereof.. . ... Universite De Strasbourg

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009


This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. is not affiliated or associated with Universite De Strasbourg in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Universite De Strasbourg with additional patents listed. Browse our Agent directory for other possible listings. Page by